---
title: An Efficient and Ultrasensitive NGS Solution for Profiling ctDNA [Poster Talk Video]
description: Our new poster talk video discusses how next-generation sequencing (NGS) of liquid biopsies offers a minimally invasive alternative to solid tissue biopsies and a more holistic profile of intra- and inter-tumoral heterogeneity for therapy selection and disease monitoring.
image: https://blog.seracare.com/hubfs/Imported_Blog_Media/Asuragen-poster-video-image-1.jpg
---

![logo](https://seracare.com/Content/themes/Skin_Default/images/lgc_logo.png)

SeraCare is part of LGC Clinical Diagnostics - [Learn More](https://www.lgcclinicaldiagnostics.com/)

[![SeraCare](https://blog.seracare.com/hs-fs/hubfs/0.%20Logos/SeraCare/SeraCare.png?width=400&name=SeraCare.png "SeraCare")](https://www.seracare.com)

- [Home](https://blog.seracare.com/ngs)
- [About](https://digital.seracare.com/about-blog)
- [News and Events](http://www.seracare.com/NewsEvents/NewsCenter/tabid/354/Default.aspx)
- [Contact](http://www.seracare.com/Contact/tabid/366/Default.aspx)

## [Diagnostic Precision](https://blog.seracare.com/)

A SeraCare blog focused on precision medicine and advanced clinical diagnostics

 Choose your Article Focus | [All](https://blog.seracare.com/molecular-serology-blog) | [NGS](https://blog.seracare.com/topic/ngs) | [Molecular & Serology](https://blog.seracare.com/molecular-serology-blog/tag/molecular-serology)

# An Efficient and Ultrasensitive NGS Solution for Profiling ctDNA \[Poster Talk Video\]

Posted by [Trevor Brown](https://blog.seracare.com/ngs/author/trevor-brown) on Mar 5, 2018 12:00:00 AM

**SeraCare Customer Poster Talk Video with Data Presented by Asuragen**

Next-generation sequencing (NGS) of liquid biopsies offers a minimally invasive alternative to solid tissue biopsies and a more holistic profile of intra- and inter-tumoral heterogeneity for therapy selection and disease monitoring. 

##### **Watch the video and download this free poster to learn:**

- How reference materials that commute to the target sample type can help to optimize ctDNA profiling technology
- Why the Seraseq ctDNA v2 Reference Material most closely resembles native ctDNA in amplifiablity and molecular diversity
- How highly patient-like reference materials allowed confident quantification of trace levels of ctDNA 

[![WATCH NOW](https://no-cache.hubspot.com/cta/default/20300467/260afe1b-cdfc-4305-8573-17afb88d02ce.png)](https://cta-redirect.hubspot.com/cta/redirect/20300467/260afe1b-cdfc-4305-8573-17afb88d02ce)

[![New call-to-action](https://no-cache.hubspot.com/cta/default/20300467/7a88e053-cfab-4f66-a543-62da5f655b2b.png)](https://cta-redirect.hubspot.com/cta/redirect/20300467/7a88e053-cfab-4f66-a543-62da5f655b2b)

 

> *We developed a technology that is able to quantify these trace levels of ctDNA. And we were able to do so because we optimized around a standard that we were confident in—that represented the targeted sample type.*
> 
> ~ Brian C. Haynes, Associate Director of Bioinformatics – Asuragen
> 
>  

 Topics: [liquid biopsy](https://blog.seracare.com/ngs/tag/liquid-biopsy), [NGS](https://blog.seracare.com/ngs/tag/ngs), [ctDNA](https://blog.seracare.com/ngs/tag/ctdna)

 

 

### Subscribe Here!

 

[![New call-to-action](https://no-cache.hubspot.com/cta/default/20300467/538d26d7-6bf8-4208-9dad-6a783db06a0c.png)](https://cta-redirect.hubspot.com/cta/redirect/20300467/538d26d7-6bf8-4208-9dad-6a783db06a0c)

### Posts by Tag

- [NGS (64)](https://blog.seracare.com/ngs/tag/ngs)
- [reference materials (37)](https://blog.seracare.com/ngs/tag/reference-materials)
- [clinical genomics (30)](https://blog.seracare.com/ngs/tag/clinical-genomics)
- [ctDNA (29)](https://blog.seracare.com/ngs/tag/ctdna)
- [cancer (24)](https://blog.seracare.com/ngs/tag/cancer)
- [SeraSeq (16)](https://blog.seracare.com/ngs/tag/seraseq)
- [cfDNA (14)](https://blog.seracare.com/ngs/tag/cfdna)
- [NIPT (12)](https://blog.seracare.com/ngs/tag/nipt)
- [RNA fusion (11)](https://blog.seracare.com/ngs/tag/rna-fusion)
- [AACR (10)](https://blog.seracare.com/ngs/tag/aacr)
- [AMP (10)](https://blog.seracare.com/ngs/tag/amp)
- [liquid biopsy (10)](https://blog.seracare.com/ngs/tag/liquid-biopsy)
- [FDA (7)](https://blog.seracare.com/ngs/tag/fda)
- [ccfDNA (7)](https://blog.seracare.com/ngs/tag/ccfdna)
- [LDT (6)](https://blog.seracare.com/ngs/tag/ldt)
- [Assay Development (5)](https://blog.seracare.com/ngs/tag/assay-development)
- [Reproductive Health (5)](https://blog.seracare.com/ngs/tag/reproductive-health)
- [Accuplex (4)](https://blog.seracare.com/ngs/tag/accuplex)
- [NTRK (4)](https://blog.seracare.com/ngs/tag/ntrk)
- [Non-invasive Prenatal Testing (4)](https://blog.seracare.com/ngs/tag/non-invasive-prenatal-testing)
- [QC Challenges (4)](https://blog.seracare.com/ngs/tag/qc-challenges)
- [qc management (4)](https://blog.seracare.com/ngs/tag/qc-management)
- [Lung Cancer (3)](https://blog.seracare.com/ngs/tag/lung-cancer)
- [MRD (3)](https://blog.seracare.com/ngs/tag/mrd)
- [New Reference Material (3)](https://blog.seracare.com/ngs/tag/new-reference-material)
- [#Quality (2)](https://blog.seracare.com/ngs/tag/quality)
- [EGFR (2)](https://blog.seracare.com/ngs/tag/egfr)
- [Inherited Disease (2)](https://blog.seracare.com/ngs/tag/inherited-disease)
- [Methylated DNA (2)](https://blog.seracare.com/ngs/tag/methylated-dna)
- [Minimal Residual Disease (2)](https://blog.seracare.com/ngs/tag/minimal-residual-disease)
- [Molecular Pathology (2)](https://blog.seracare.com/ngs/tag/molecular-pathology)
- [PGT (2)](https://blog.seracare.com/ngs/tag/pgt)
- [QC Management Software (2)](https://blog.seracare.com/ngs/tag/qc-management-software)
- [TMB (2)](https://blog.seracare.com/ngs/tag/tmb)
- [Women's health (2)](https://blog.seracare.com/ngs/tag/womens-health)
- [myeloid cancer reference materials (2)](https://blog.seracare.com/ngs/tag/myeloid-cancer-reference-materials)
- [ngs validation (2)](https://blog.seracare.com/ngs/tag/ngs-validation)
- [trisomy (2)](https://blog.seracare.com/ngs/tag/trisomy)
- [zika virus (2)](https://blog.seracare.com/ngs/tag/zika-virus)
- [BioFidelity (1)](https://blog.seracare.com/ngs/tag/biofidelity)
- [Breast Cancer (1)](https://blog.seracare.com/ngs/tag/breast-cancer)
- [COVID-19 (1)](https://blog.seracare.com/ngs/tag/covid-19)
- [Customer Testimonial (1)](https://blog.seracare.com/ngs/tag/customer-testimonial)
- [Genomic Testing (1)](https://blog.seracare.com/ngs/tag/genomic-testing)
- [HIV (1)](https://blog.seracare.com/ngs/tag/hiv)
- [Immuno-Oncology (1)](https://blog.seracare.com/ngs/tag/immuno-oncology)
- [PGS (1)](https://blog.seracare.com/ngs/tag/pgs)
- [PGT-A (1)](https://blog.seracare.com/ngs/tag/pgt-a)
- [Preimplantation genetic testing (1)](https://blog.seracare.com/ngs/tag/preimplantation-genetic-testing)
- [QC Reporting (1)](https://blog.seracare.com/ngs/tag/qc-reporting)
- [QC data management (1)](https://blog.seracare.com/ngs/tag/qc-data-management)
- [Quality Management Systems (1)](https://blog.seracare.com/ngs/tag/quality-management-systems)
- [SARS-CoV-2 (1)](https://blog.seracare.com/ngs/tag/sars-cov-2)
- [bioinformatics (1)](https://blog.seracare.com/ngs/tag/bioinformatics)
- [laboratory training (1)](https://blog.seracare.com/ngs/tag/laboratory-training)
- [listeria (1)](https://blog.seracare.com/ngs/tag/listeria)
- [methylated (1)](https://blog.seracare.com/ngs/tag/methylated)

See all

### Recent Posts

**About SeraCare**

With over 30 years of experience as a leading partner to global in vitro diagnostics manufacturers and clinical testing laboratories, SeraCare’s clinical genomics technologies enable the promise of precision medicine by helping scientists and clinicians build and implement better clinical genomics assays. [Learn More](http://www.seracare.com/Company/WhoWeAre/tabid/335/Default.aspx) 

 

- <https://www.facebook.com/SeraCare>
- <https://twitter.com/seracare>
- <https://www.linkedin.com/company/seracare-life-sciences>

[Privacy Policy](http://www.seracare.com/PrivacyPolicy/tabid/211/Default.aspx)  |  [Legal Statement ](http://www.seracare.com/LegalStatement/tabid/212/Default.aspx)

**Learn More**

[Home](http://seracare.com/)   
[About Us](http://seracare.com/Company/WhoWeAre/tabid/335/Default.aspx)  
[News and Events](http://www.seracare.com/NewsEvents/NewsCenter/tabid/354/Default.aspx)   
[Blog](https://blog.seracare.com/)   
[Contact](http://seracare.com/Contact/tabid/366/Default.aspx) 

![LGC+Marine-logo-FINAL-teal](https://blog.seracare.com/hs-fs/hubfs/1.%20Logos/LGC+Marine-logo-FINAL-teal.png?width=150&name=LGC+Marine-logo-FINAL-teal.png)

37 Birch Street

Milford, MA 01757  
[508-244-6400](tel:508-244-6400) l [800-676-1881](tel:800-676-1881)  
[info@seracare.com](mailto:info@seracare.com)

©2017 SeraCare Life Sciences, Inc.

- [About SeraCare](http://www.seracare.com/Company/WhoWeAre/tabid/335/Default.aspx)
- [Learn More](http://seracare.com/)

- 37 Birch Street Milford, MA 01757
- Google Maps
- 508-244-6400
- 508-634-3334 Fax

- <https://www.facebook.com/SeraCare>
- <https://twitter.com/seracare>
- <https://www.linkedin.com/company/seracare-life-sciences>

![logo](https://blog.seracare.com/hubfs/logo.png "logo")

37 Birch Street  
Milford, MA 01757

508-244-6400  
508-634-3334 Fax

<https://www.facebook.com/SeraCare/> <https://twitter.com/SeraCare> <https://www.linkedin.com/company/seracare-life-sciences/>

#### Products

#### SeraCare

#### Support & Resources

- NGS & Digital PCR Tools
- Controls & Reference Materials
- Validation & Qualification Materials
- Plasma & Serum Diluents & Derivatives
- Cell Culture Reagents
- KPL Antibodies & Conjugates
- KPL Immunoassay Reagents & Kits

- About Us
- Careers
- Press Releases
- News Articles
- Quality Systems
- Terms & Conditions
- Privacy Policy & Legal Statement

- Register for an Account
- Contact Us
- Sign In
- Resource Library
- FAQs
- Scientific Posters
- White Papers
- Videos

```json
{
  "@context" : "https://schema.org",
  "@type" : "BlogPosting",
  "author" : {
    "@type" : "Person",
    "name" : "Trevor Brown",
    "url" : "https://blog.seracare.com/ngs/author/trevor-brown"
  },
  "dateModified" : "2021-10-15T01:28:53.866Z",
  "datePublished" : "2018-03-05T05:00:00.000Z",
  "headline" : "An Efficient and Ultrasensitive NGS Solution for Profiling ctDNA [Poster Talk Video]",
  "image" : [ "https://blog.seracare.com/hubfs/Imported_Blog_Media/Asuragen-poster-video-image-1.jpg" ],
  "mainEntityOfPage" : {
    "@id" : "https://blog.seracare.com/ngs/efficient-ultrasensitive-ngs-solution-profiling-ctdna-poster-video",
    "@type" : "WebPage"
  },
  "publisher" : {
    "@type" : "Organization",
    "logo" : {
      "@type" : "ImageObject",
      "url" : "https://blog.seracare.com/hubfs/0.%20Logos/SeraCare/SeraCare.png"
    },
    "name" : "LGC Clinical Diagnostics"
  }
}
```